Press Releases

Sign up for the latest news

You can unsubscribe at any time using the link at the bottom of any newsletter or contacting info@predictimmune.com

Stay up to date with the latest press releases from PredictImmune and discover how its prognostic tools could help improve the lives of patients with autoimmune diseases through better treatment.

PredictImmune announces closure of £10 Million series B funding round

PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product pipeline New and existing investors demonstrate strong confidence in the developer of unique and pioneering prognostic tools to...

PredictImmune confirms Canadian patent grant

PredictImmune confirms Canadian patent grant Patent covers PredictImmune’s intellectual property relating to methods for predicting autoimmune disease risk Cambridge, UK, 22nd January 2019: PredictImmune, developers of pioneering prognostic tools for guiding treatment...

PredictImmune gains ISO 13485 medical devices certification

PredictImmune makes further strides towards January launch of PredictSURE IBD, by gaining ISO 13485 medical devices certification Certification demonstrates PredictImmune’s on-going commitment to the provision of high-quality processes to support the development of...

PredictImmune awarded Innovate UK grant

PredictImmune awarded Innovate UK grant to apply its biomarker-based technology towards the prediction of drug response in IBD. Developer of the PredictSURE IBD™ prognostic test awarded £100K from Innovate UK’s ‘Precision medicine technologies: shaping the future’...